2000
DOI: 10.1016/s0924-9338(00)94092-6
|View full text |Cite
|
Sign up to set email alerts
|

FC05.04 Influence of pharmacologically different antidepressants on neurocognition of patients with depressive disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2010
2010
2010
2010

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…In addition, aspects about individuals’ course of illness—such as number of depressive episodes and duration of episodes, as well as age at onset of depression—may impact cognitive performance. Treatment resistance is also a relevant consideration, as it contributes to longer episodes, as well as the likelihood for exposure to more types of psychotropic medications and combinations of psychotropic medications for a longer period of time, which is negatively associated with cognitive function (Gibel & Ritsner, 2008; Neumann et al, 2002).…”
Section: Defining Depression Severitymentioning
confidence: 99%
“…In addition, aspects about individuals’ course of illness—such as number of depressive episodes and duration of episodes, as well as age at onset of depression—may impact cognitive performance. Treatment resistance is also a relevant consideration, as it contributes to longer episodes, as well as the likelihood for exposure to more types of psychotropic medications and combinations of psychotropic medications for a longer period of time, which is negatively associated with cognitive function (Gibel & Ritsner, 2008; Neumann et al, 2002).…”
Section: Defining Depression Severitymentioning
confidence: 99%